Skip to main content
. Author manuscript; available in PMC: 2012 Aug 6.
Published in final edited form as: Mol Cell Endocrinol. 2011 Jun 1;342(1-2):20–31. doi: 10.1016/j.mce.2011.05.023

FIGURE 4. Change in the relative level of AR and corepressors in prostate cancer progression.

FIGURE 4

Expression of AR and the corepressors NCOR1 and NCOR2/SMRT derived from published Affymetrix array profiling experiments in clinical prostate cancer samples (Holzbeierlein et al. 2004; Scher et al. 2004). Relative log2 expression of AR/SMRT or AR/NCOR1. primary, primary prostate cancer; AAT, primary cancer following short-term androgen deprivation therapy; BM, bone metastases; metastatic, metastatic prostate cancer.